
Longer follow-up of the phase 2 LUNAR trial showed a 62% lower risk of progression, additional hormone therapy or death with 177Lu-PNT2002 plus radiation.
More information on cancer-related cognitive changes.
For more information on cancer-related cognitive changes, including dementia, delirium, and chemobrain, view “Cognitive Changes” at
about 17 years ago
The Final Journey: The Life and Death of Judy Abernathyover 17 years ago
Web Exclusive: What Is a "Good Death?"over 17 years ago
Web Exclusive: Resolving Your Own Deathover 17 years ago
Web Exclusive: Understanding Hospiceover 17 years ago
Web Exclusive: Find a Clinical Trial That's Right for Youover 17 years ago
Web Exclusive: Find a Clinical Trial That's Right for Youover 17 years ago
Web Exclusive: Eulogy for Dr. Phillip Bermanover 17 years ago
Web Exclusive: A Granddaughter's Eulogyover 17 years ago
Calming Cancer Painover 17 years ago
Excerpt: When Hormone Therapy Can Stress You OutStay up to date on cancer updates, research and education
Subscribe





